Management of histologically indolent non-Hodgkin's lymphomas

被引：11
|
作者：
SolalCeligny, P
机构：
[1] Department of Haematology, Centre J. Bernard, 72000 Le Mans
来源：
BAILLIERES CLINICAL HAEMATOLOGY | 1996年 / 9卷 / 04期
关键词：
D O I：
10.1016/S0950-3536(96)80048-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Histologically indolent lymphomas which represent 40-50% of all non-Hodgkin's lymphomas encompass small lymphocytic lymphomas, follicular lymphomas and other entities more recently described such as mantle cell and marginal zone lymphomas. Their management has benefited from new drugs such as interferon a the purine analogues and new treatment modalities especially autologous stem cell transplantation.
引用
收藏
页码：669 / 687
页数：19
相关论文
共 50 条
  • [21] Non-Hodgkin's Lymphomas
    Jardin, Fabrice
    Tilly, Herve
    [J]. HEMATOLOGIE, 2006, 12 : 17 - 24
  • [22] Morphometric Study of Trephine Biopsy Specimens in Aggressive and Indolent Non-Hodgkin’s Lymphomas
    N. P. Domnikova
    G. I. Nepomnyashchikh
    S. V. Aidagulova
    M. A. Bakarev
    T. Yu. Dolgikh
    I. V. Kachesov
    E. E. Petrusenko
    [J]. Bulletin of Experimental Biology and Medicine, 2011, 151 : 764 - 768
  • [23] Oral fludarabine/cyclophosphamide combination in pretreated indolent non-Hodgkin's lymphomas.
    Zinzani, PL
    Musuraca, G
    Stefoni, V
    Marchi, E
    Tani, M
    Alinari, L
    Gabriele, A
    Baccarani, M
    [J]. BLOOD, 2003, 102 (11) : 285B - 285B
  • [24] Morphometric Study of Trephine Biopsy Specimens in Aggressive and Indolent Non-Hodgkin's Lymphomas
    Domnikova, N. P.
    Nepomnyashchikh, G. I.
    Aidagulova, S. V.
    Bakarev, M. A.
    Dolgikh, T. Yu.
    Kachesov, I. V.
    Petrusenko, E. E.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 151 (06) : 764 - 768
  • [25] Morphological Characteristics of the Central Compartment of the Erythron in Aggressive and Indolent Non-Hodgkin’s Lymphomas
    T. Yu. Dolgikh
    N. P. Domnikova
    E. E. Petrusenko
    N. A. Mal’tseva
    I. V. Kachesov
    [J]. Bulletin of Experimental Biology and Medicine, 2011, 151
  • [26] The emerging role of Bortezomib in the treatment of indolent non-Hodgkin's and mantle cell lymphomas
    O'Connor O.A.
    [J]. Current Treatment Options in Oncology, 2004, 5 (4) : 269 - 281
  • [27] Hodgkin's disease and non-Hodgkin lymphomas
    Gutiérrez, EO
    [J]. REVISTA CLINICA ESPANOLA, 1999, 199 : 44 - 51
  • [28] Morphological Characteristics of the Central Compartment of the Erythron in Aggressive and Indolent Non-Hodgkin's Lymphomas
    Dolgikh, T. Yu.
    Domnikova, N. P.
    Petrusenko, E. E.
    Mal'tseva, N. A.
    Kachesov, I. V.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 151 (02) : 259 - 263
  • [29] Management of AIDS-Related Non-Hodgkin’s Lymphomas
    Marie José Kersten
    Rien H. J. Van Oers
    [J]. Drugs, 2001, 61 : 1301 - 1315
  • [30] Cladribine in indolent non-Hodgkin's lymphoma
    Sigal, Darren S.
    Saven, Alan
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (04) : 535 - 545
12345